Companies/US/SLN

SILENCE THERAPEUTICS PLC

Income flow

Annual
SLN 10-K Income StatementPeriod 2025-12-31Source 10-K
Research Collaboration Income$559,000Revenue$559,000-99% Y/YGross profit$344,000-99% Y/YCost of revenue$215,000

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-12-31 · 10-K · USD
By activity
By activity$559,000
  • Research Collaboration Income$559,000100.0%
By geography
By geography$559,000
  • GB$559,000100.0%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.0.0%Shares outTotal shares currently outstanding (issued and not retired).62.2MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).37.9M